These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15814907)

  • 1. Cerebral MR imaging in uninfected children born to HIV-seropositive mothers and perinatally exposed to zidovudine.
    Tardieu M; Brunelle F; Raybaud C; Ball W; Barret B; Pautard B; Lachassine E; Mayaux MJ; Blanche S
    AJNR Am J Neuroradiol; 2005 Apr; 26(4):695-701. PubMed ID: 15814907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new challenge for the neuroradiologist: MR recognition of mitochondrial dysfunction in children born of HIV-seropositive mothers on antiretroviral therapy.
    Post MJ
    AJNR Am J Neuroradiol; 2005 Apr; 26(4):687-9. PubMed ID: 15814902
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.
    Barret B; Tardieu M; Rustin P; Lacroix C; Chabrol B; Desguerre I; Dollfus C; Mayaux MJ; Blanche S;
    AIDS; 2003 Aug; 17(12):1769-85. PubMed ID: 12891063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.
    Blanche S; Tardieu M; Rustin P; Slama A; Barret B; Firtion G; Ciraru-Vigneron N; Lacroix C; Rouzioux C; Mandelbrot L; Desguerre I; Rötig A; Mayaux MJ; Delfraissy JF
    Lancet; 1999 Sep; 354(9184):1084-9. PubMed ID: 10509500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
    Lindegren ML; Rhodes P; Gordon L; Fleming P; ;
    Ann N Y Acad Sci; 2000 Nov; 918():222-35. PubMed ID: 11131709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.
    Divi RL; Walker VE; Wade NA; Nagashima K; Seilkop SK; Adams ME; Nesel CJ; O'Neill JP; Abrams EJ; Poirier MC
    AIDS; 2004 Apr; 18(7):1013-21. PubMed ID: 15096804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered heterochromatin organization after perinatal exposure to zidovudine.
    Senda S; Blanche S; Costagliola D; Cibert C; Nigon F; Firtion G; Floch C; Parat S; Viegas-Péquignot E
    Antivir Ther; 2007; 12(2):179-87. PubMed ID: 17503660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.
    Poirier MC; Divi RL; Al-Harthi L; Olivero OA; Nguyen V; Walker B; Landay AL; Walker VE; Charurat M; Blattner WA;
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):175-83. PubMed ID: 12794551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.
    Patel K; Van Dyke RB; Mittleman MA; Colan SD; Oleske JM; Seage GR;
    AIDS; 2012 Oct; 26(16):2027-37. PubMed ID: 22781228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of definitive severe mitochondrial signs and symptoms among deceased HIV-uninfected and HIV-indeterminate children < or = 5 years of age, Pediatric Spectrum of HIV Disease project (PSD), USA.
    Dominguez K; Bertolli J; Fowler M; Peters V; Ortiz I; Melville S; Rakusan T; Frederick T; Hsu H; D'Almada P; Maldonado Y; Wilfert C;
    Ann N Y Acad Sci; 2000 Nov; 918():236-46. PubMed ID: 11131710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Zidovudine-associated mitochondriopathy: three possible observations in Abidjan, Côte d'Ivoire].
    Elenga N; Msellati P; Fassinou P; Viho I; Dabis F
    Bull Soc Pathol Exot; 2004 Nov; 97(4):253-6. PubMed ID: 17304745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.
    Lipshultz SE; Easley KA; Orav EJ; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; Sopko G; McIntosh K; Colan SD
    N Engl J Med; 2000 Sep; 343(11):759-66. PubMed ID: 10984563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.
    de Souza RS; Gómez-Marín O; Scott GB; Guasti S; O'Sullivan MJ; Oliveira RH; Mitchell CD
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):154-61. PubMed ID: 10935691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
    Benhammou V; Warszawski J; Bellec S; Doz F; André N; Lacour B; Levine M; Bavoux F; Tubiana R; Mandelbrot L; Clavel J; Blanche S;
    AIDS; 2008 Oct; 22(16):2165-77. PubMed ID: 18832880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.